 |
인쇄하기
취소
|
Hanmi to bolster tie-up with CrystalGenomics for new drug development
Hanmi Pharm has forged a strategic alliance with CrystalGenomics, a local bioventure firm, to boost its joint research and development projects for new drugs.
Under the agreement, Hanmi will invest 30 billion won to CrystalGenomics in the forms of paid-in capital increase and bond with warrant.
We will maintain a strategic alliance with CrystalGenomics to development new drugs,'' Lim Sun...
Under the agreement, Hanmi will invest 30 billion won to CrystalGenomics in the forms of paid-in capital increase and bond with warrant.
We will maintain a strategic alliance with CrystalGenomics to development new drugs,'' Lim Sun...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.